undamentalytics Newsletter
Sign in

Aclarion, Inc. balance sheet

At the end of fiscal 2025, Aclarion, Inc. had total assets of $13.7m, total liabilities of $837,287 and shareholders' equity of $12.8m. It held $12.0m in cash against $0 of debt: net cash of $12.0m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents01101216
Receivables000000
Total current assets12111217
Total assets23221418
Accounts payable101101
Total current liabilities813111
Long-term debt—0000—
Total debt200000
Total liabilities8—3111
Shareholders' equity−132−111317
Non-controlling interests and other (assets − liabilities − equity)7—————
Net debt (negative = net cash)2−1−1−0−12−16
Shares outstanding14m————2m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ACON vs ISPCACON vs YDESACON vs QSI

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Aclarion, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aclarion, Inc.